Custom Recombinant Protein Production Services Market Outlook, and Opportunity

Posted by Rajkumar on September 3rd, 2019

Custom recombinant protein production plays a major role in advanced healthcare and is the most efficient technique used in life sciences. Recombinant proteins are used in a wide range of applications in research, biotechnology, and medicine.

The global custom recombinant protein production services market size was valued at US$ 2,600.21 million in 2017, and is expected to exhibit a CAGR of 11.2% over the forecast period (2018 – 2026).

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2737

Increasing funding in the field of life sciences is expected to propel growth of the custom recombinant protein production services market

Recombinant protein is a manipulated form of protein, which is encoded by genes. It is used in production of large quantities of protein, which is further used for manufacturing of therapeutic commercial products. Increasing government initiatives and funding in the field of life sciences is expected to boost growth of the market. For instance, Life Sciences Greenhouse of Central Pennsylvania offers early stage funding of up to US$ 1-2 million in the form of convertible debt or equity financing to viable life sciences companies, which have significant potential for commercial growth.

Moreover, advancements in bioreactor systems have facilitated production of recombinant protein within shorter time span, which in turn is expected to propel growth of the custom recombinant protein production services market over the forecast period. For instance, according to National Centre for Biotechnology Information (NCBI), in 2014, around 65.6% of clinical scale manufacturers and 42% of commercial manufacturers adopted single-use bioreactors for improvement in their bioprocessing.

Increasing research and development and product launches in North America is expected to bolster the market growth

North America is expected to hold dominant position in the global custom recombinant protein production services market, owing to increasing focus of regional players in research and development and product launches. For instance, in 2014, Western Blot Service CRO, a division of Altogen Lab, launched automated WES protein analysis and protein expression services, providing a complete platform to conduct protein expression studies.

Moreover, the companies in the region are focused on adopting strategic acquisitions to expand their geographic presence. For instance, in 2017, Eurofins Scientific acquired DiscoverX to improve research productivity and accelerate the discovery and development of new drugs. The acquisition is also expected to create a robust portfolio of kinase products and services in the market.

Market Dynamics

Increasing demand for recombinant proteins for basic research has supported growth of the custom recombinant protein production services market. Recombinant therapeutic proteins are one of the fast-growing areas in molecular medicine. Various biopharmaceutical companies are focusing on development of biologics and subsequently biosimilars. Moreover, increasing expenditure in research has supported the market growth. The R&D spending of the U.S. is around 2.7% of its Gross Domestic Products (GDP) with highest R&D investments observed in the biotechnology segment in 2014, according to American Pharmaceutical Review.

Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/market-insight/custom-recombinant-protein-production-services-market-2737

Key Players

Major players operating in the custom recombinant protein production services market include, GenScript Biotech Corporation, Applied Biological Materials Inc., Eurofins Pharma Discovery Services, Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc., BPS Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech, Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS, LakePharma, Inc., Proteos, Inc., Aldevron, and Sino Biological Inc.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Like it? Share it!


Rajkumar

About the Author

Rajkumar
Joined: February 13th, 2019
Articles Posted: 590

More by this author